Kate Karlin, MD, MS is a Gastroenterology Fellow and NIH T32 Research Fellow at the Perelman School of Medicine, where she is pursuing a Master of Science in Health Policy Research. Dr. Karlin’s research background is in decision analysis and health economics, with multiple peer-reviewed publications in cost-effectiveness modeling, health technology assessment, and real-world outcomes research in inflammatory bowel disease. Her research interests center on pharmaceutical access and payment policy in IBD, examining how insurance design and payment structures affect whether patients receive biologic therapy, and the resulting clinical and economic consequences. She is interested in bringing rigorous health economic methods to questions at the intersection of clinical care, insurance design, and the biopharmaceutical industry.
Dr. Karlin earned her MD and MS from Columbia University Vagelos College of Physicians and Surgeons, followed by residency in Internal Medicine at Duke University.